Glucotrol Xl
Indicated to address chronic blood glucose levels to support metabolic optimisation and manage diabetic complications.
- Category
- Diabetes Management
- Active ingredient
- Glipizide
- Route
- Oral use
- Form
- Extended-Release Tablet
- Strengths
- 2.5mg · 5mg · 10mg
Prescription and consultation requirements for Glucotrol Xl vary by destination and are determined by the fulfilment partner.
Glucotrol Xl details
- Condition
- Type 2 Diabetes Mellitus
- Alternative names
- glipizide
- Therapeutic class
- Sulfonylurea
- Pharmacological class
- Antidiabetic
- Contraindications
- diabetic ketoacidosis; type 1 diabetes mellitus; severe hepatic impairment
- Minor side effects
- nausea; dizziness; headache
- Moderate side effects
- hypoglycaemia; weight gain; flatulence
- Dosage forms
- Extended-Release Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Pfizer
- Onset Time
- 1–3 hours
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- NSAIDs; Warfarin; Beta Blockers
- Age restrictions
- Approved for adults.
Serious side effects
severe hypoglycaemia, requires immediate medical attention; haemolytic anaemia, requires immediate medical attention
Patient summary
indicated to address chronic blood glucose levels to support metabolic optimisation and manage diabetic complications.
Mechanism of action
Stimulates beta cells in the pancreas to release endogenous insulin, reducing circulating postprandial glucose levels.
Pregnancy and breastfeeding
TGA Category C: Avoid in late pregnancy due to risk of neonatal hypoglycaemia. Breastfeeding: Not recommended.